Related Experiment Video
Updated: Dec 24, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass
Xiaolong Ma1, Ran Dong1, Pengfei Chen1
1Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Insights
Diabetic patients with prior coronary artery bypass grafting (CABG) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) showed similar outcomes to non-diabetic patients. This finding suggests comparable safety and efficacy for PCI in diabetic individuals post-CABG.
Area of Science:
- Cardiology
- Interventional Cardiology
- Diabetes Mellitus Research
Background:
- Prior coronary artery bypass grafting (CABG) surgery is a significant factor in managing coronary artery disease.
- Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) is an alternative revascularization strategy.
- Understanding outcomes in diabetic versus non-diabetic patients post-CABG undergoing PCI is crucial for clinical decision-making.
Purpose of the Study:
- To compare the long-term clinical outcomes of PCI using DES in diabetic versus non-diabetic patients who have previously undergone CABG.
- To evaluate the safety and efficacy of PCI in this specific patient population.
Main Methods:
- A retrospective study included 724 patients who received PCI with DES after CABG between 2009 and 2017.
- Patients were divided into diabetes mellitus (DM) and non-diabetes mellitus (No DM) groups.
- A 1:1 propensity score-matched analysis was performed, adjusting for relevant risk factors, with a median follow-up of 5.13 years.
Main Results:
- While the event rates for major adverse cardiac events (MACEs) were numerically higher in the DM group at 2, 5, and 8 years, no statistically significant difference was observed in overall MACEs (HR: 1.35; P=0.052) or its components including cardiac death, myocardial infarction (MI), heart failure (HF), or revascularization.
- Subgroup analysis focusing on PCI in the native coronary artery (NCA) also revealed no significant differences in MACEs, cardiac death, MI, HF, or revascularization between the DM and No DM groups.
Conclusions:
- Subsequent implantation of DES in the native coronary artery of diabetic patients following CABG resulted in outcomes comparable to those in non-diabetic patients.
- These findings suggest that PCI with DES is a viable and safe treatment option for diabetic patients with prior CABG.
Background:
The target of this study was to explore the outcomes of percutaneous coronary intervention (PCI) in diabetic versus non-diabetic patients with prior coronary artery bypass grafting (CABG) surgery.
Methods:
Seven hundred and twenty four patients who had previously received CABG and had been treated using PCI combined with drug-eluting stents (DES) between 2009 and 2017 were selected for a retrospective study and allocated into either a diabetes mellitus (DM) or non-diabetes mellitus (No DM) group. A 1:1 propensity score-matched evaluation was conducted and risk adjusted for analysis. The primary outcomes were cardiac death, myocardial infarction, heart failure and revascularization, with a median follow-up duration of 5.13 years.
Results:
After matching, two-, 5- and 8-year event rate of overall major adverse cardiac events (MACEs) were found to be higher in the DM group (No DM vs DM:15.3, 30.9, 38.5% vs 19.8, 37.8, 52.2%, respectively), although no significant difference was found in the event rate of overall MACEs (hazard ratio [HR]: 1.35; 95% confidence interval [CI]: 1.00 to 1.83 for DM vs No DM; P = 0.052), cardiac death (HR: 0.94; 95% CI: 0.45 to 1.95; P = 0.871), MI (HR: 1.49; 95% CI: 0.95 to 2.32; P = 0.080), HF (HR: 1.54; 95% CI: 0.90 to 2.63 for; P = 0.120) or revascularization (HR: 1.07; 95% CI: 0.72 to 1.59; P = 0.747). Subgroup analysis of PCI in only the NCA showed MACEs (adjusted HR: 1.13; 95% CI: 0.85 to 1.49 for DM vs No DM; P = 0.325), cardiac death (adjusted HR: 0.85; 95% CI: 0.41 to 1.78 for DM vs No DM; P = 0.781), MI (adjusted HR: 1.32; 95% CI: 0.84 to 2.01 for DM vs No DM; P = 0.069), HF (adjusted HR: 1.41; 95% CI: 0.87 to 2.27 for DM vs No DM; P = 0.211) or repeated revascularization (adjusted HR: 0.93; 95% CI: 0.64 to 1.37 for DM vs No DM; P = 0.836).
Conclusions:
Compared with non-diabetic patients with prior CABG, subsequent implantation of DES in the native coronary artery of diabetic patients resulted in apparently similar outcomes.
Trial Registration:
This study was not registered in an open access database.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management

